Skip to content
Back to treatments
Regenerative Medicine~67% less than U.S.

Stem Cell Therapy for Heart Disease

心脏病干细胞治疗

Duration
2-4 weeks treatment; 6-12 months follow-up
Recovery
1-2 weeks post-procedure; cardiac improvement assessed at 3-6 months
Average savings
67%
价格对比Price comparison

China versus the U.S.

China
$14,000
Range: $8,000–$20,000
United States
$42,500
Range: $25,000–$60,000
You save
67%
~$28,500 per procedure
China clinical rate
$8,000 – $20,000
$14,000
United States
$25,000 – $60,000
$42,500
You save
~67%
$28,500 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Cardiac stem cell therapy for heart failure, ischemic cardiomyopathy, and post-myocardial infarction recovery using mesenchymal stem cells or cardiac progenitor cells. Chinese cardiovascular centers conduct clinical trials delivering stem cells via intracoronary, intramyocardial, or intravenous routes to promote cardiac repair. Programs combine cell therapy with optimized heart failure management.

流程Procedure steps

Step by step.

  1. 01

    Cardiac Assessment

    Echocardiography, cardiac MRI, coronary angiography, and ejection fraction measurement

    Duration · 2-3 days
  2. 02

    Cell Preparation

    Autologous bone marrow harvest or allogeneic MSC selection and quality testing

    Duration · 1-2 weeks
  3. 03

    Cell Delivery

    Intracoronary infusion during catheterization or intramyocardial injection via specialized catheter

    Duration · 1-2 hours
  4. 04

    Cardiac Rehabilitation

    Structured cardiac rehab program with serial echocardiography and functional capacity testing

    Duration · 3-6 months
Benefits
  • Potential to improve ejection fraction and reduce heart failure symptoms
  • Chinese cardiovascular centers have extensive catheter-based delivery experience
  • Combined with optimal medical and rehabilitative care
  • May reduce hospitalizations for heart failure
Considerations
  • Arrhythmia risk during and after cell delivery
  • Experimental nature with variable clinical outcomes
  • Catheterization procedure carries inherent vascular risks
  • Long-term benefit duration uncertain
下一步Next step

Ask the AI for hospitals that handle stem cell therapy for heart disease.

Ask AIRequest consultation

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.